Ciwon mara mai cutar kansa

Ciwon mara mai cutar kansa

Maimaitawa cokali mai yatsa - kayan aiki don gano cutar rashin hankalin jijiyoyin jiki
ICD-10G 63.2 63.2, E 10.4 10.4, E 11.4 11.4, E 12.4 12.4, E 13.4 13.4, E 14.4 14.4
ICD-9250.6 250.6
ICD-9-KM250.6
Karafarini000693
RagaD003929

Ciwon mara mai cutar kansa (wasu Girkanci νεϋρον - "jijiya" + sauran Girkanci πάθος - "wahala, rashin lafiya") - rikice-rikice na tsarin juyayi wanda ke hade da shan kashi na ciwon sukari na ƙananan ƙwayoyin jini (vasa vasorum, vasa nervorum) - ɗaya daga cikin mafi yawan abubuwa rikitarwa, ba wai kawai haifar da rage ƙarfin aiki ba, har ma yana haifar da raunin raunin da ya faru da mutuwar marasa lafiya. Tsarin ilimin jijiyoyin cuta yana shafar dukkanin ƙwayoyin jijiya: azanci, moto da kuma na kai. Ya danganta da matakin lalacewar wasu zaruruwa, ana lura da bambance bambancen cututtukan cututtukan zuciya masu ƙoshin jini: azanci (hankali), azanci-Mota, mai cin gashin kai (m). Rarrabe tsakanin tsakiya da na waje neuropathy. Dangane da rarrabewar V. M. Prikhozhan (1987), lalacewar kwakwalwa da igiyar kashin baya ana ɗauka azaman neuropathy na tsakiya kuma saboda haka an kasafta shi zuwa:

Hadarin Cerebrovascular

| gyara lambar

A duk lokacin da ake fama da ciwon sukari, hadarin kamuwa da cutar bugun zuciya na karuwa. Dangane da sakamakon binciken da aka yi na dogon lokaci, an gano cewa yawan lokuta masu fama da cutar mahaifa a tsakanin mutane masu fama da cutar sankarau sun kai 62.3 a cikin mutane 1,000, yayin da a cikin manyan mutane shi ne mutum 32.7 cikin mutane 1,000 a cikin shekaru 12 na tsawon shekaru. lura. Ko yaya dai, abin da ya faru na hauhawar jini da haɗarin jijiyoyin jiki bai bambanta da wannan ga yawan jama'a ba. An tabbatar da cewa cutar sankarau tana haifar da haɗari ga haɓakar haɗarin cerebrovascular, ba tare da la'akari da kasancewar wasu abubuwan haɗari ba (hauhawar jijiyoyin jini, hypercholesterolemia).

Koyaya, hanyar bugun jini ischemic a tsakanin mutanen da ke fama da ciwon sukari ya fi tsanani a cikin yanayi, mummunan ci gaba, ƙarancin mace-mace da nakasa idan aka kwatanta da bugun jini a cikin yawan jama'a ba tare da ciwon sukari ba. A cikin wani binciken da Lithner et al ya gudanar a 1988, yawan mace-macen masu rauni a tsakanin mutane masu fama da cutar sankara shine kashi 28%, kuma tsakanin mutane da ba su da ciwon sukari, 15%. Babban haɓakawa na haɓakar ƙwaƙwalwar ƙwaƙwalwa yana haifar da mummunar hanya da sakamako na bugun jini wanda aka nuna akan asalin ciwon sukari mellitus. Wani bincike na annoba na Amurka ya gano cewa hadarin maimaita hatsarin cerebrovascular bayan bugun farko a tsakanin mutanen da ke dauke da ciwon sukari ya ninka sau 5.6 sama da matakin irin wannan haɗari a cikin mutanen da suka sami bugun jini amma basu da ciwon suga (Alter da et al., 1993).

Ofimar hyperglycemia a matsayin tushen ci gaba a yayin bugun jini har yanzu ta kasance mai jayayya tsakanin mutane da kuma ba tare da ciwon sukari ba. Hyperglycemia yana haɗuwa sau da yawa tare da ciwo mai rauni: a gefe guda, yana iya zama alama ta mellitus na ciwon sukari wanda ba'a sani ba a baya, kuma a gefe guda, yana haifar da abubuwan damuwa da ke tattare da ci gaban bugun jini. A lokaci guda, yawan ciwon sukari mellitus da aka gano yayin hawan bugun jini (ba a gano shi a baya ba) ya kasance mafi girma kuma, bisa ga binciken daban-daban, daga 6 zuwa 42%. A cikin 1990, Davalos et al. Ab Kafa dangantaka mai ƙarfi tsakanin tsananin, sakamakon bugun jini, da gulukon jini a lokacin asibiti. Koyaya, tambayar ba tukuna ta fayyace ba: shine hyperglycemia mai haɗarin haɗari mai zaman kanta don haɓaka hanyar haɗarin cerebrovascular ko kawai yana nuna tsananin ƙarfin bugun jini, ƙarar sa da kuma fassarar ƙasa.

Binciken epidemiological na marasa lafiya 411 tare da nau'in ciwon sukari na 2 na 2, wanda aka gudanar a cikin tsawon shekaru 7, ya gano cewa azumin glucose na jini yana daidaita da yawan mace-macen marasa lafiya daga cututtukan tsarin zuciya kuma ya kasance babban hadarin haɗari mai zaman kansa don haɓakar macroangiopathy, ciki har da cututtukan cerebrovascular .

Leave Your Comment